摘要或動機

p53 蛋白是一種轉錄調控因子，其在抑制癌症的形成扮演很重要的角色。已知的報告顯示它能影響下游特定蛋白表現進而調控細胞週期或促使細胞進行凋亡作用。如此作用機制對於可能癌化的細胞在生物體造成傷害之前能被先行消滅，因此正常的p53 蛋白存在與否，對癌症的產生有很大的影響。 根據上述結果，我們想分析不同表現量的p53 是否對於致癌藥劑-EtBr所引發的癌化細胞有所影響。所以我們設計實驗，將具有正常表現量p53 蛋白的老鼠(p53+/+)與僅能表現少量p53 蛋白的老鼠(p53+/-)，均塗以等劑量之致癌藥劑EtBr於其大腿皮膚上，觀察其致癌情形的差異。實驗結果發現 : 在塗EtBr 的14 隻p53+/-老鼠中，有3 隻出現了組織病變的症狀，包括脾臟腫大，淋巴組織長出腫瘤，而其他對照組(一)塗EtBr 的p53+/+老鼠，(二)不塗EtBr 的p53+/+老鼠或(三)不塗EtBr 的p53+/-老鼠都沒有產生異常的症狀。因此根據上述實驗結果進行推論，發現經EtBr 的刺激後，p53+/-的老鼠的確較其他的老鼠更容易得到癌化細胞。;p53 is a transcription factor that plays an important role in suppression of tumorgenesis. Previous reports showed it regulates cell cycle and enhances cell apoptosis by effecting specific proteins expression. By this way, the problematic tumor cell can be deleted to protect organism from tumor damage. According above conclusion, we are interested to know whether p53 plays a role involved the carcinogens-EtBr induced tumorgenesis. We compared the differences of tumorgenesis between mice express normal (p53+/+) or low (p53+/-) expression level of p53 proteins when they are smeared equal amount of EtBr on skin of thigh. In here, our results show three of fourteen p53+/- mice had pathological changes, containing spleen enlargement and lymphoma. However, other three comparisons, smear p53+/+ mice with EtBr (1), without EtBr (2) or p53+/- without EtBr(3), are normal. Therefore, We suggest that p53+/- mice are easily to obtain tumor than p53+/+ mice after EtBr treatment.